Overview of Endofalk (Macrogol)

Property	Description
Active ingredient	Macrogol (Polyethylene Glycol or PEG)
Form	Powder for oral solution (sachet)
Pharmacological class	Osmotic laxative / Cathartic agent
Common use	Bowel preparation before diagnostic procedures
Origin	Synthetic polymer

Endofalk is a prescription medicine formulated as a specialized bowel cleansing agent, classified as a potent osmotic laxative. Its primary function is to achieve the necessary bowel clearance for procedures, a process clinically recognized for its reliability in establishing a clear internal environment.

What Type of Medicine is Endofalk (Macrogol)?

Endofalk belongs to the class of cathartic agents with the active ingredient being Macrogol, which is the common term for Polyethylene Glycol (PEG). Macrogol is an inert polyether derived from ethylene oxide, classifying it as a synthetic polymer. This medicine is defined by its pharmacological class as an osmotic laxative because it achieves its effect through a purely physical, non-stimulant mechanism, retaining water within the intestine. Unlike simpler Macrogol formulations focused only on general constipation management, Endofalk is specifically positioned and formulated as a dedicated, high-dose bowel preparation product, as consistently demonstrated by its inclusion in specialized hospital formularies.

Composition, Form, and Origin of the Preparation

Endofalk is supplied as a powder for oral solution packaged in individual sachets, which must be dissolved in water before administration. The preparation is a combination product that includes essential electrolytes in addition to the Macrogol itself. The inclusion of salts, such as sodium chloride, sodium bicarbonate, and potassium chloride, is critical to maintain the body's overall fluid and electrolyte balance during the massive fluid shift caused by the osmotic action, ensuring the solution is isosmotic. Macrogol preparations used for bowel cleansing are formulated with electrolytes to prevent fluid and electrolyte disturbances.

What is the General Purpose of Endofalk?

The general purpose of Endofalk is to achieve the complete and rapid evacuation of the bowel, essentially flushing the intestinal tract clean. This action ensures that the entire colon is free of solid contents, which is the necessary prerequisite for successful visual inspection during diagnostic procedures like colonoscopy, as well as for certain surgical operations. The core benefit is providing physicians with a pristine, unobstructed internal view for accurate examination and treatment planning.

Regulatory References

Polyethylene Glycol - NIH

What side effects are possible with Endofalk (Macrogol)?

Possible side effects and safety information

The safety profile of Endofalk is structured around common gastrointestinal effects and the risk of serious systemic complications related to fluid and electrolyte balance.

Adverse Reaction Categories (Based on Regulatory Classification)

Frequency	Common Adverse Reactions	System-Organ Classes
Very Common (1/10)	Nausea, feeling of fullness, flatulence, abdominal distension.	Gastrointestinal Disorders
Common (1/100 to <1/10)	Vomiting, gastric colics, irritation of the anus.	Gastrointestinal Disorders
Not Known	Anaphylactic shock, dehydration, electrolyte disorders (e.g., hypocalcaemia, hyponatraemia), generalised seizures, cardiac arrhythmias, lung edema, Mallory-Weiss syndrome (bleeding due to tearing of the gullet from severe vomiting).	Immune System, Metabolism, Nervous System, Cardiac, Respiratory, Gastrointestinal

Serious and Clinically Significant Safety Concerns

Serious adverse reactions documented in regulatory sources include anaphylactic shock and severe electrolyte disturbances (such as low sodium or potassium levels), which can lead to complications like generalised seizures, neurological effects (ranging from disorientation), and cardiac arrhythmias. The administration of the product should be immediately stopped, and electrolytes measured, if symptoms indicating significant shifts of fluid/electrolytes occur.

Safety Restrictions and Contraindications

Endofalk is contraindicated in patients with known or suspected ileus, gastro-intestinal obstruction or perforation, toxic megacolon, hyperflorid colitis, or severe inflammatory bowel disease. Caution is required, and use should be under medical supervision, in patients who are elderly or debilitated, or those with pre-existing heart failure, kidney failure (Grade III and IV), liver disease, or cardiac rhythm disturbances. The product is not recommended for use in patients with severe dehydration, and is contraindicated in unconscious patients due to the risk of aspiration.

Overdose and Emergency Response

Overdose and When to Seek Help

This information is strictly based on the official overdose sections of government regulatory documents and prescribing information.

Documented Overdose Manifestations

Category	Official Regulatory Statement
Documented Manifestations	Overdose primarily results in severe diarrhoea. Other symptoms may include severe abdominal pain and distension.
Severe Outcomes	Derangement of the electrolyte and water balance and/or the acid and base balance is expected in a severe overdose. Toxic lung oedema can develop in the event of aspiration.

Required Emergency Actions

Category	Official Regulatory Statement
Urgent Medical Help	Patients must seek immediate medical attention or contact a Poison Control Center right away in all cases of overdose.
Aspiration Risk	If aspiration of the solution occurs, immediate intensive care is required due to the risk of toxic lung oedema.
Supportive Management	Management involves adequate replacement of fluids, monitoring of the serum electrolytes and pH, and adjusting the electrolyte or acid-base balance. No specific antidote is known for this overdose.

The official overdose profile is defined by the consequences of excessive osmotic action, specifically the massive fluid loss leading to severe diarrhoea and potential metabolic derangement. These regulatory statements mandate immediate care for all overdose events and detail the critical supportive procedures required to address fluid, electrolyte, and pulmonary complications.

Therapeutic Uses of Endofalk (Macrogol)

What Endofalk (Macrogol) Treats: Main Uses and Benefits

Endofalk (Macrogol) is a medicine intended to help manage symptoms related to a few core conditions, primarily by acting as an osmotic laxative. Its main uses fall into two categories: relieving uncomfortable digestive symptoms and preparing the bowel for medical procedures.

The medicine is used to address chronic constipation and assist with the management of fecal impaction (severe, persistent constipation). For patients, this offers symptom relief by helping to soften stools and supporting more comfortable bowel function.

Endofalk (Macrogol) is also utilized for full bowel cleansing prior to a procedure, such as an endoscopy, radiography, or surgery. This preparation is an important part of supporting a high-quality medical examination.

Quick Fact: Relief for Occasional and Chronic Constipation

Eligibility and Restrictions for Use

The use of Endofalk is strictly defined by regulatory guidelines based on population eligibility. Adults who do not present any contraindications or restriction criteria may use this medicine.

Absolute Prohibitions and Restrictions

Endofalk is contraindicated and must not be used in patients with acute gastrointestinal issues, including Gastro-intestinal obstruction or perforation, ileus, toxic megacolon, or known hypersensitivity to any of its components.

The medicine is prohibited for the paediatric population (children and adolescents) as its use is not established in this age group. Use is also restricted for patients who are unconscious or have an impaired swallowing reflex, due to the serious risk of aspiration.

Use is generally not recommended for patients with severe heart failure (Grade III and IV), severe kidney failure (Grade III and IV), liver diseases, or severe dehydration, as safety has not been adequately demonstrated in these conditions. Conditional use requiring close medical supervision is necessary for elderly patients and those with pre-existing conditions like Reflux Oesophagitis or cardiac arrhythmias.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documentation confirms that Endofalk (Macrogol/Polyethylene Glycol with electrolytes), when used as a bowel cleansing agent, exhibits two primary interaction patterns: reduced absorption and pharmacodynamic risk.

Pharmacokinetic Interaction via Reduced Absorption

The preparation causes reduced systemic absorption for virtually all co-administered oral medications. This effect, due to the rapid gastrointestinal transit induced by the osmotic action, formally reduces the therapeutic efficacy of essential medicines such as the Oral Contraceptive Pill, Digoxin, and Antiepileptics. This necessitates mandatory timing separation rules for administration.

Timing-Based Separation Requirements

Substance Class	Mandatory Rule (per regulatory label)
General Oral Medicines	Must be taken at least 1 hour before starting Macrogol.
Specific Oral Medicines (e.g., Digoxin, Iron Supplement, certain Antibiotics)	Must be taken at least 2 hours before or 6 hours after the Macrogol dose.

Pharmacodynamic and Restriction Interactions

Co-administration with medicines that affect fluid or electrolyte balance, such as Diuretics, NSAIDs, ACE Inhibitors, or ARBs, is officially documented as increasing the risk of fluid and electrolyte disturbances, which may lead to cardiac arrhythmias or renal impairment. Regulatory labels explicitly prohibit combining this preparation with other laxatives due to the documented risk of colonic mucosal ulcerations. Additionally, the consumption of alcohol, milk, and solid food is restricted during the preparation period.

Mechanism of Action

How Endofalk (Macrogol) Works

Modulation of Intestinal Water Dynamics via Osmosis

Macrogol is a non-absorbed osmotic agent that acts within the bowel lumen, its primary site of action. By remaining unabsorbed across the intestinal epithelium, it establishes a high solute concentration, creating an osmotic gradient that passively draws and retains water from the surrounding tissues into the intestinal lumen. This mechanism targets the fluid content of the gut, initiating a mechanistic cascade that alters the physical environment of the colon.

Physical Regulation of Fecal Bulk and Consistency

Water retained by the osmotic action integrates into the fecal mass, resulting in a modification of its physical properties. This process leads to the modulation of fecal bulk and consistency, resulting in a stool with modified rheological properties and elevated volume. This physiological effect mechanically distends the colon, which engages normal regulatory feedback mechanisms within the enteric nervous system that stimulate peristalsis.

Dosage and Administration Information

Official Administration Guidelines for Bowel Cleansing

The administration of Endofalk (high-dose Macrogol with electrolytes) is a precise, time-constrained protocol for achieving complete bowel clearance. It is supplied as a powder for oral solution and is strictly for oral use.

Total Dosing and Preparation The standard total dose for an adult (≥ 18 years of age) requires consuming 3 to a maximum of 4 litres of the reconstituted solution. The powder, packaged in sachets, must be dissolved in a specific volume of water (e.g., two sachets dissolved to make 1 litre of solution). It is a mandatory instruction to not add any non-prescribed ingredients, such as sugar or external flavouring, to the prepared mixture, as the combination already contains essential electrolytes. The reconstituted solution must be used within 24 to 48 hours, depending on the specific product label, often requiring refrigeration for optimal palatability.

Consumption Schedule and Timing Administration follows a fractional consumption schedule, where the solution is not taken as a single dose but is consumed in portions of approximately 200 to 300 mL (about 8 ounces) every 10 to 15 minutes until the full volume is consumed, or the rectal discharge is clear. The entire course is generally administered over a 4-hour period using either a single-day or split-dose regimen relative to the time of the examination. Patients must fast from solid food starting at least 2 to 3 hours before administration begins. All fluid intake must cease at least 2 hours before the procedure. Due to its action, oral medications should be avoided within 1 hour before and after the solution is taken.

Recent Clinical Evidence

Endofalk (Macrogol): Recent Clinical Evidence

Evidence for Bowel Preparation Before Medical Procedures

Macrogol was studied for research exploring how bowel clearance is measured before diagnostic procedures, such as colonoscopy, or prior to certain surgeries. Randomized Controlled Trials (RCTs) were designed to compare Macrogol-based regimens with other cleansing agents, examining outcomes related to physical discomfort and the measured status of the bowel clearance. Systematic reviews describe these preparations as a standardized approach. Research continues to explore methods related to patient adherence, as the large liquid volume required may sometimes lead to difficulties with tolerability.

Evidence for Symptomatic Treatment of Chronic Constipation

Macrogol was studied for the symptomatic treatment of conditions characterized by functional limitations, such as chronic constipation. RCTs, including placebo-controlled trials, compared Macrogol with other laxatives like lactulose. Research examined outcomes reflecting daily functioning or activity level, such as the frequency of bowel movements and changes in stool consistency. The measured outcomes were observed in some studies during the defined time intervals.

Evidence for Acute Resolution of Fecal Impaction

Macrogol was evaluated in studies focusing on acute or disruptive episodes, specifically the resolution of fecal impaction. This research explored the outcomes related to resolving the obstruction, with many trials focusing on pediatric patients (children and adolescents).

Evidence in Special Populations and Research Limitations

Research has explored the use of Macrogol for constipation and fecal impaction in pediatric patients and older adults. For chronic constipation, some studies extended to research examining responses over defined time intervals spanning up to six or twelve months. However, evidence quality varies across studies due to heterogeneity in design and patient criteria. Data for certain specific groups remain insufficient, and follow-up durations were limited in many trials focusing on acute use.

Frequently Asked Questions (FAQ)

Common questions about Endofalk (Macrogol) (FAQ)

Q: Can Endofalk (Macrogol) cause dehydration?

A: Regulatory documents indicate that fluid or electrolyte disturbances can potentially occur with Macrogol preparations. For this reason, the product is not recommended for use in patients with severe pre-existing dehydration. Monitoring of electrolyte levels is an aspect that may be discussed with a healthcare provider.

Q: Is it normal to feel bloated after taking Endofalk (Macrogol)?

A: Yes, official product information lists a 'feeling of fullness' and 'abdominal distension' as very common side effects. Bloating or a feeling of being full is a typical part of the process as the Macrogol draws and retains large amounts of fluid into the bowel.

Q: Are there any specific food or drinks that should be avoided with Endofalk (Macrogol)?

A: Official instructions specify restrictions on certain items during the preparation period. Consumption of solid food, milk, and alcohol is restricted. Furthermore, no additives, such as sugar or external flavouring, should be added to the prepared solution itself.

Q: Does Endofalk (Macrogol) contain any sugar or sweeteners?

A: Regulatory documents confirm the composition includes Macrogol and electrolytes. There are separate warnings against adding sugar or external flavourings to the prepared solution, as this is prohibited.

Q: Is there a risk of becoming dependent on Endofalk (Macrogol)?

A: Macrogol is an osmotic agent that works physically by drawing water into the bowel, and it is not absorbed systemically. Regulatory guidance does not list dependence as a common risk. Official information confirms that Endofalk is indicated for acute bowel cleansing, which is a short-term, specialized regimen.

Q: What happens if I miss a dose of Endofalk (Macrogol)?

A: Official instructions describe a process for addressing a forgotten portion. Regulatory information notes that failure to complete the full required quantity may result in incomplete bowel clearance, which could prevent the intended medical procedure from being carried out successfully.

Q: Does Endofalk (Macrogol) change the color or consistency of stool?

A: Official product information states that the preparation modifies the consistency of the fecal mass by adding fluid, leading to a complete and rapid evacuation of the bowel. Successful bowel cleansing is confirmed when the rectal discharge is clear liquid only.

Q: Is Endofalk (Macrogol) available without a prescription?

A: Endofalk is classified as a 'prescription medicine.' It is formulated as a specialized, high-dose cathartic agent for use prior to diagnostic procedures, which generally requires professional medical authorization.

Q: Can Endofalk (Macrogol) cause an allergic reaction?

A: Official safety information lists the potential for hypersensitivity reactions. These can range from less severe reactions like a rash or hives (urticaria) to severe reactions, including anaphylactic shock.

Q: Is it possible to take Endofalk (Macrogol) at night?

A: Yes, administration instructions confirm that the total course can follow either a single-day or a split-dose regimen. For morning procedures, the split-dose regimen typically involves taking a portion of the solution in the evening before the examination day.

Q: Is it typical for Macrogol to cause increased gas?

A: Yes, official regulatory documents list 'flatulence' as a very common side effect of the preparation. This production of gas is a normal occurrence associated with the fluid dynamics in the bowel.

Q: What is the physical feeling expected when Endofalk (Macrogol) starts working?

A: Official safety documents describe common expected effects as a 'feeling of fullness' and 'abdominal distension' (bloating) due to the fluid accumulation in the bowel. These physical sensations are often described as part of the action of the preparation.

Q: How is Macrogol's effect described compared to traditional fiber supplements?

A: Regulatory medical information classifies Macrogol as an osmotic laxative. This means it works through a physical mechanism, drawing water into the intestine. This mechanism is different from that of traditional fiber supplements, which typically work by adding indigestible bulk to the stool.

Q: Is it necessary to finish the entire preparation of Endofalk (Macrogol)?

A: Official instructions state that the solution is to be consumed until the rectal discharge is clear liquid only. Consuming less than the recommended full quantity may lead to incomplete bowel cleansing, which could prevent a successful diagnostic examination.

Q: Does Endofalk (Macrogol) have different formulations for different purposes?

A: The specific product Endofalk is designated as a specialized, high-dose, electrolyte-containing bowel cleansing agent. This formulation makes it distinct from lower-dose Macrogol preparations that are commonly available for managing chronic constipation.

Q: How is the taste of Endofalk (Macrogol) generally described?

A: The official composition includes essential salts, which contribute to a characteristic salty or medicinal taste. Preparation guidelines recommend chilling the solution before consumption as this is noted to help improve palatability.

Q: What are the typical non-gastrointestinal side effects reported for Endofalk (Macrogol)?

A: Official safety information reports non-digestive side effects such as headache, dizziness, and signs of fluid or electrolyte disturbances, which may include swelling of the ankles or tiredness. Serious risks include neurological effects like seizures and cardiac arrhythmias.

Q: Is it OK if the Endofalk (Macrogol) solution is cloudy?

A: Official preparation instructions state that the solution should be stirred until it is 'clear or slightly hazy.' This suggests that some slight cloudiness or haziness in the solution after proper mixing is an expected appearance.

Q: Is a metallic or salty taste expected when taking Endofalk (Macrogol)?

A: Yes, the presence of essential salts (electrolytes) in the preparation contributes to its taste profile. Chilling the solution is an official recommendation often employed to help manage the taste.

Q: How long can a person expect to use Endofalk (Macrogol)?

A: Endofalk is specifically indicated for acute bowel preparation, which is a temporary treatment. The entire course of the preparation is typically administered over a short time frame, usually approximately four hours, prior to a medical procedure, and is not intended for extended use.

Q: What are the most common side effects listed for Endofalk (Macrogol)?

A: The most common side effects listed in official documents are very common gastrointestinal effects. These include nausea, a feeling of fullness, flatulence, and abdominal distension.

Q: Can Endofalk (Macrogol) cause abdominal pain or cramping?

A: Yes, 'gastric colics,' which refers to abdominal cramping or pain, is listed as a common side effect in regulatory documents. This effect is a known part of the process of rapid bowel evacuation.

Q: Can Endofalk (Macrogol) affect blood pressure or electrolyte levels?

A: Official regulatory documents explicitly note the risk of serious 'electrolyte disorders,' such as low sodium or potassium levels. These disturbances can lead to complications including 'cardiac arrhythmias' (irregular heart rhythm).

Q: Is Endofalk (Macrogol) safe to use during pregnancy?

A: Official regulatory documents indicate that there is a lack of established experience with the use of Endofalk during pregnancy. Its use in this context requires assessment by a physician.

Q: Is Endofalk (Macrogol) safe for children to use?

A: Official regulatory information states that this specific Macrogol product is prohibited for the paediatric population, which includes children and adolescents. Its use for bowel preparation is not established in this age group.

Q: Can Endofalk (Macrogol) affect how other medicines are absorbed?

A: Yes, official documents confirm that the preparation causes reduced systemic absorption for virtually all co-administered oral medications. This occurs because the rapid transit of the solution through the gastrointestinal tract can reduce the time other medicines have to be absorbed.

Q: Can Endofalk (Macrogol) be used for routine constipation or only for bowel preparation?

A: Endofalk is specifically designated as a high-dose, specialized bowel preparation product for diagnostic procedures like colonoscopy. It is not indicated or formulated for the routine or chronic management of constipation.

Q: Can Endofalk (Macrogol) interact with herbal supplements?

A: The preparation causes reduced absorption for virtually all co-administered oral medicines. This means that the preparation may reduce the systemic absorption of any co-administered oral product, including herbal supplements.

Q: Can Endofalk (Macrogol) be taken with antacids?

A: Official documents confirm that co-administered oral medicines, which includes antacids, may have their systemic absorption reduced by the preparation due to rapid transit. This is an official, documented interaction pattern.

Q: How should the unused prepared solution be handled?

A: To help protect the environment, any unused or expired Endofalk must not be disposed of via wastewater or ordinary household waste. Patients are advised to consult a pharmacist for instructions on the proper method for disposing of medicines no longer required.

How should Endofalk (Macrogol) be stored and disposed of?

How to Store and Dispose of Endofalk (Macrogol)?

Official regulatory information defines storage and disposal requirements based on the medicine's form.

Storage Requirements

The powder for oral solution does not require any special storage conditions prior to preparation and must not be used after the expiry date.
The prepared solution must be stored for no longer than 3 hours at room temperature (below 25°C).
Alternatively, the prepared solution can be stored in the refrigerator (between 2°C and 8°C) for a maximum of 48 hours.
It is mandatory to keep this medicine out of the sight and reach of children.

Disposal Instructions

To help protect the environment, unused or expired Endofalk must not be disposed of via wastewater or household waste.

Consult a pharmacist for instructions on proper disposal of medicines no longer required.

Endofalk (Macrogol)